These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31630275)
61. Hepatitis C virus infection in African patients with liver cirrhosis or primary hepatocellular carcinoma. Mets T; Smitz J; Ngendahayo P; Sabbe L; Bigilimana I; Ngirabatware B Scand J Gastroenterol; 1993 Apr; 28(4):331-4. PubMed ID: 8387695 [TBL] [Abstract][Full Text] [Related]
62. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
63. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Leung NW; Tam JS; Lai JY; Leung TW; Lau WY; Shiu W; Li AK Cancer; 1992 Jul; 70(1):40-4. PubMed ID: 1318777 [TBL] [Abstract][Full Text] [Related]
64. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262 [TBL] [Abstract][Full Text] [Related]
65. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma. Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524 [TBL] [Abstract][Full Text] [Related]
66. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan. Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029 [TBL] [Abstract][Full Text] [Related]
67. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Sun CA; Wu DM; Lin CC; Lu SN; You SL; Wang LY; Wu MH; Chen CJ Am J Epidemiol; 2003 Apr; 157(8):674-82. PubMed ID: 12697571 [TBL] [Abstract][Full Text] [Related]
68. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620 [TBL] [Abstract][Full Text] [Related]
69. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617 [TBL] [Abstract][Full Text] [Related]
70. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Fattovich G Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1206-13. PubMed ID: 9730376 [TBL] [Abstract][Full Text] [Related]
71. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861 [TBL] [Abstract][Full Text] [Related]
72. Hepatocellular carcinoma and hepatitis C in Mexico. Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652 [TBL] [Abstract][Full Text] [Related]
73. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan. Abdul Mujeeb S; Jamal Q; Khanani R; Iqbal N; Kaher S Trop Doct; 1997 Jan; 27(1):45-6. PubMed ID: 9030022 [TBL] [Abstract][Full Text] [Related]
74. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142 [TBL] [Abstract][Full Text] [Related]
75. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [TBL] [Abstract][Full Text] [Related]
77. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042 [TBL] [Abstract][Full Text] [Related]
78. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology. Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130 [TBL] [Abstract][Full Text] [Related]
79. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Benvegnù L; Alberti A Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830 [TBL] [Abstract][Full Text] [Related]
80. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia. Kurbanov F; Tanaka Y; Elkady A; Oyunsuren T; Mizokami M J Viral Hepat; 2007 Sep; 14(9):667-74. PubMed ID: 17697020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]